ACKRELL
CAPITAL

| December 2017

Cannabis Investment Report

Summary of U.S. Publicly Traded Cannabis-Related Companies

(As of November 30, 2017)

Average ($U.S. millions)

LTM LTM
Revenue EBITDA
$44.0 -$81.1
46 -1.2
(3 -6.5
14.0 0.2
$14.5 -$1.4

Number of Market Enterprise

Companies Value Value Cash Debt
Nasdaq 4 $1,033.6 $884.5 $153.6 $4.5
NYSE 1 63.5 41.3 22.2 0.0
NYSE American 2 eal 145.7 78 1.4
OTC 212 46.3 65.5 5.7 25.0
United States 219 $65.5 $81.2 $8.5 $24.3

Source: S&P Global Market Intelligence. Companies that are traded on more than one market are included in their primary market as determined
by S&P Global Market Intelligence, based on stock price history, trading volume and availability of estimates. Enterprise Value is defined as
Market Value plus Debt minus Cash and Cash Equivalents. LTM is Last Twelve Months. EBITDA is defined as Earnings Before Interest, Taxes,

Depreciation and Amortization.

Stock Price Performance of U.S. Publicly Traded

Cannabis-Related Companies

The following chart shows the stock price performance of selected publicly traded cannabis-related
companies in the United States since September 30, 2016. As shown in this chart, the election of
Donald Trump as President and the selection of Jeff Sessions as Attorney General of the United States
have not slowed the continuing positive price performance of cannabis-related companies trading on

U.S. markets.

U.S. Cannabis Stock Price Performance

800%

100%

Sessions confirmed
as U.S. Attorney
General

600%

500%

Trump
elected as
U.S. President

400%

300%
200%
100%

0% eee

—100%

Sep 16 Nov 16 Jan 17

—— S&P 500

Mar 17 May 17 Jul 17

Nasdaq/NYSE Cannabis Index

Sep 17 Nov 17

—— OTC Cannabis Index

Source: S&P Global Market Intelligence

122

© 2017 Ackrell Capital, LLC

| Member FINRA/SIPC

HOUSE_OVERSIGHT_024758
